FDA Says No Cardio Risk with Olmesartan in Diabetes Patients
After completing a safety review, the US Food and Drug Administration (FDA) found no evidence that the blood pressure medication olmesartan increases cardiovascular risks in people with diabetes.
Diabetics Benefit from Blood Pressure Drug
Type 2 diabetics are exposed to many health risks, including developing kidney problems. New research shows that a common blood pressure drug may help these patients protect their kidneys.